Cargando…
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma
Ovarian cancer is one of the neoplasms affecting the reproductive tract associated with high mortality rate because of limited therapeutic options and an elevated incidence of chemoresistance and recurrence. In this context, immunotherapy may constitute a promising approach to improve survival rates...
Autores principales: | Agarwal, Sumit, Saini, Shikha, Parashar, Deepak, Verma, Archana, Sinha, Abhilasha, Jagadish, Nirmala, Batra, Aruna, Suri, Sushma, Gupta, Anju, Ansari, Abdul S., Lohiya, Nirmal Kumar, Suri, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667910/ https://www.ncbi.nlm.nih.gov/pubmed/23762804 http://dx.doi.org/10.4161/onci.24270 |
Ejemplares similares
-
A Novel Cancer Testis Antigen, A-Kinase Anchor Protein 4 (AKAP4) Is a Potential Biomarker for Breast Cancer
por: Saini, Shikha, et al.
Publicado: (2013) -
Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells
por: Kumar, Vikash, et al.
Publicado: (2017) -
Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy
por: Sinha, Abhilasha, et al.
Publicado: (2013) -
Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012) -
A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer
por: Jagadish, Nirmala, et al.
Publicado: (2015)